Highly modular bow-tie gene circuits with programmable dynamic behaviour

Nature Communications

Volumn 5, Issue , 2014, Pages

  Prochazka, Laura ^a   Angelici, Bartolomeo ^a   Haefliger, Benjamin ^a   Benenson, Yaakov ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 141; MICRORNA 142; MICRORNA 146A; RECOMBINASE; SYNTHETIC DNA; UNCLASSIFIED DRUG; PROTEIN;

BIOTECHNOLOGY; DESIGN; GENE EXPRESSION; OPTIMIZATION; PROTEIN; RNA;

ARTICLE; CELL THERAPY; CONTROLLED STUDY; GENE CONSTRUCT; GENE DOSAGE; GENE STRUCTURE; GENETIC TRANSFECTION; HEK293 CELL LINE; HELA CELL LINE; HIGHLY MODULAR BOW TIE GENE CIRCUIT; HUMAN; HUMAN CELL; IN VITRO STUDY; PROMOTER REGION; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; SYNTHETIC BIOLOGY; TRANSCRIPTION INITIATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM;

GENE REGULATORY NETWORKS; HEK293 CELLS; HUMANS; MICRORNAS; PROTEINS;

EID: 84935753969     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5729     Document Type: Article

References (55)

1. Leplatois, P. & Danchin, A. Vectors for high conditional expression of cloned genes. Biochimie 65, 317-324 (1983).
2. Lewandoski, M. Conditional control of gene expression in the mouse. Nat. Rev. Genet. 2, 743-755 (2001).
3. Beier, K. T., Samson, M. E. S., Matsuda, T. & Cepko, C. L. Conditional expression of the TVA receptor allows clonal analysis of descendents from cre-expressing progenitor cells. Dev. Biol. 353, 309-320 (2011).
4. Lois, C., Hong, E. J., Pease, S., Brown, E. J. & Baltimore, D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868-872 (2002).
5. Martinez-Gonzalez, I., Moreno, R., Petriz, J., Gratacos, E. & Aran, J. M. Engraftment potential of adipose tissue-derived human mesenchymal stem cells after transplantation in the fetal rabbit. Stem Cells Dev. 21, 3270-3277 (2012).
6. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
7. Heise, C. et al. ONYX-015, an E1B gene-attenuated adenovirus, causes tumorspecific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med. 3, 639-645 (1997).
8. Wang, Y. B. et al. Tissue-specific and development-specific expression of the human phenylalanine-hydroxylase chloramphenicol acetyltransferase fusion gene in transgenic mice. J. Biol. Chem. 267, 15105-15110 (1992).
9. Morel, C., Cordierbussat, M. & Philippe, J. The upstream promoter element of the glucagon gene, G1, confers pancreatic alpha cell-specific expression. J. Biol. Chem. 270, 3046-3055 (1995).
10. Gong, S. C. et al. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425, 917-925 (2003).
11. Beer, S. et al. Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol. 2, 1785-1798 (2004).
12. Felsher, D. W. & Bishop, J. M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199-207 (1999).
13. Siegert, S. et al. Transcriptional code and disease map for adult retinal cell types. Nat. Neurosci. 15, 487-495 (2012).
14. Nettelbeck, D. M., Jerome, V. & Muller, R. Gene therapy: designer promoters for tumour targeting. Trends Genet. 16, 174-181 (2000).
15. Brown, B. D. et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat. Biotechnol. 25, 1457-1467 (2007).
16. Chen, J., Kwon, C. H., Lin, L., Li, Y. J. & Parada, L. F. Inducible site-specific recombination in neural stem/progenitor cells. Genesis 47, 122-131 (2009).
17. Peng, Y. F. et al. Alpha-fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy. PLoS ONE 8, e53072 (2013).
18. Utomo, A. R. H., Nikitin, A. Y. & Lee, W. H. Temporal, spatial, and cell type-specific control of CRE-mediated DNA recombination in transgenic mice. Nat. Biotechnol. 17, 1091-1096 (1999).
19. Gardner, T. S., Cantor, C. R. & Collins, J. J. Construction of a genetic toggle switch in Escherichia Coli Nature 403, 339-342 (2000).
20. Baker, D. et al. Engineering life: building a FAB for biology. Sci. Am. 294, 44-51 (2006).
21. Elowitz, M. B. & Leibler, S. A synthetic oscillatory network of transcriptional regulators. Nature 403, 335-338 (2000).
22. Rinaudo, K. et al. A universal RNAi-based logic evaluator that operates in mammalian cells. Nat. Biotechnol. 25, 795-801 (2007).
23. Kemmer, C. et al. Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nat. Biotechnol. 28, 355-360 (2010).
24. Chen, Y. Y., Jensen, M. C. & Smolke, C. D. Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems. Proc. Natl Acad. Sci. USA 107, 8531-8536 (2010).
25. Ye, H. F., Daoud-El Baba, M., Peng, R. W. & Fussenegger, M. A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science 332, 1565-1568 (2011).
26. Auslander, S., Auslander, D., Muller, M., Wieland, M. & Fussenegger, M. Programmable single-cell mammalian biocomputers. Nature 487, 123-127 (2012).
27. Leisner, M., Bleris, L., Lohmueller, J., Xie, Z. & Benenson, Y. Rationally designed logic integration of regulatory signals in mammalian cells. Nat. Nanotechnol. 5, 666-670 (2010).
28. Xie, Z., Wroblewska, L., Prochazka, L., Weiss, R. & Benenson, Y. Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science 333, 1307-1311 (2011).
29. Burrill, D. R., Inniss, M. C., Boyle, P. M. & Silver, P. A. Synthetic memory circuits for tracking human cell fate. Gene Dev. 26, 1486-1497 (2012).
30. Nevozhay, D., Zal, T. & Balazsi, G. Transferring a synthetic gene circuit from yeast to mammalian cells. Nat. Commun. 4, 1451 (2013).
31. Weber, W. et al. A synthetic mammalian gene circuit reveals antituberculosis compounds. Proc. Natl Acad. Sci. USA 105, 9994-9998 (2008).
32. Csete, M. & Doyle, J. Bow ties, metabolism and disease. Trends Biotechnol. 22, 446-450 (2004).
33. Haynes, K. A., Ceroni, F., Flicker, D., Youngers, A. & Silver, P. A. A sensitive switch for visualizing natural gene silencing in single cells. ACS Synth. Biol. 1, 99-106 (2012).
34. Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998).
35. Yoo, A. S. et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 476, 228-231 (2011).
36. Anokye-Danso, F. et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8, 376-388 (2011).
37. Cheung, T. H. et al. Maintenance of muscle stem-cell quiescence by microRNA-489. Nature 482, 524-528 (2012).
38. Landgraf, P. et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414 (2007).
39. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005).
40. Wilson, K. D. et al. MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev. 18, 749-757 (2009).
41. He, M. et al. Cell-type-based analysis of MicroRNA profiles in the mouse brain. Neuron 73, 35-48 (2012).
42. Shimshek, D. R. et al. Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis 32, 19-26 (2002).
43. Raymond, C. S. & Soriano, P. High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS ONE 2, e162 (2007).
44. Keravala, A. et al. Mutational derivatives of PhiC31 integrase with increased efficiency and specificity. Mol. Ther. 17, 112-120 (2009).
45. Kaczmarczyk, S. J. & Green, J. E. A single vector containing modified cre recombinase and LOX recombination sequences for inducible tissue-specific amplification of gene expression. Nucleic Acids Res. 29, e56 (2001).
46. Atasoy, D., Aponte, Y., Su, H. H. & Sternson, S. M. A FLEX switch targets channelrhodopsin-2 to multiple cell types for imaging and long-range circuit mapping. J. Neurosci. 28, 7025-7030 (2008).
47. Turan, S., Kuehle, J., Schambach, A., Baum, C. & Bode, J. Multiplexing RMCE: Versatile extensions of the Flp-recombinase-mediated cassette-exchange technology. J. Mol. Biol. 402, 52-69 (2010).
48. Weber, W., Kramer, B. P., Fux, C., Keller, B. & Fussenegger, M. Novel promoter/transactivator configurations for macrolide-and streptograminresponsive transgene expression in mammalian cells. J. Gene Med. 4, 676-686 (2002).
49. Weber, W. et al. Macrolide-based transgene control in mammalian cells and mice. Nat. Biotechnol. 20, 901-907 (2002).
50. Salghetti, S. E., Caudy, A. A., Chenoweth, J. G. & Tansey, W. P. Regulation of transcriptional activation domain function by ubiquitin. Science 293, 1651-1653 (2001).
51. Kurosu, T. & Peterlin, B. M. VP16 and ubiquitin: Binding of P-TEFb via its activation domain and ubiquitin facilitates elongation of transcription of target genes. Curr. Biol. 14, 1112-1116 (2004).
52. Lapique, N. & Benenson, Y. Digital switching in a biosensor circuit via programmable timing of gene availability. Nat. Chem. Biol. doi: 10.1038/NCHEMBIO.1680 (2014).
53. Fussenegger, M. et al. Streptogramin-based gene regulation systems for mammalian cells. Nat. Biotechnol. 18, 1203-1208 (2000).
54. Qian, L. L. & Winfree, E. Scaling up digital circuit computation with DNA strand displacement cascades. Science 332, 1196-1201 (2011).
55. Jayanthi, S., Nilgiriwala, K. S. & Del Vecchio, D. Retroactivity controls the temporal dynamics of gene transcription. ACS Synth. Biol. 2, 431-441 (2013).